Five Things to Know About Esketamine April 8, 2020 In March 2019, intranasal esketamine—a form of ketamine marketed as SPRAVATO™ CIII Nasal Spray*—was approved by the U.S. Food and Read More >
4 Things We Now Know About Treatment-Resistant Depression April 8, 2020 For many people coping with major depressive disorder—which includes different types of depression that persist for at least two weeks—antidepressants can Read More >